ACE Inhibition versus Angiotensin Receptor Blockade: Which Is Better for Renal and Cardiovascular Protection? | American Society of Nephrology
ASK DIS: ARB Dose Conversions
Should ACE-inhibitors and ARBs be stopped with COVID-19? — NephJC
WO2009061713A1 - Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor - Google Patents
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
Valsartan Recall Information for Patients and Prescribers - English
An Overview of Generic Angiotensin Receptor Blockers
NKF KDOQI Guidelines
Table 1 from ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008. | Semantic Scholar
ARB Approximate Dose Equivalence for BP Lowering and ... | GrepMed